Eliezer Masliah Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

1/2022	Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies.
1/2021	Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer's Disease.
12/2020	Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability.
10/2020	LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies.
7/2020	Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models.
1/2020	Immunotherapies for Aging-Related Neurodegenerative Diseases-Emerging Perspectives and New Targets.
1/2020	Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic Models.
1/2020	The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies.
10/2019	Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies.
1/2019	Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eliezer Masliah Research Topics

Disease

166	Parkinson Disease (Parkinson's Disease) 05/2022 - 03/2002
162	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2001
98	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2001
94	Dementia (Dementias) 05/2022 - 05/2002
63	Synucleinopathies 01/2022 - 02/2002
33	Multiple System Atrophy 10/2020 - 06/2002
31	Cognitive Dysfunction 01/2022 - 10/2002
26	Amyloid Plaque 10/2020 - 07/2002
26	Lewy Body Disease (Lewy Body Dementia) 07/2020 - 03/2002
22	Inflammation (Inflammations) 05/2022 - 07/2003
22	Neuroinflammatory Diseases 01/2021 - 11/2005
21	Neurocognitive Disorders (Clerambault Syndrome) 01/2020 - 04/2006
19	Gliosis 07/2020 - 07/2003
18	HIV Infections (HIV Infection) 10/2019 - 06/2002
18	Encephalitis (Encephalitis, Rasmussen) 01/2019 - 06/2002
17	Huntington Disease (Huntington's Disease) 11/2018 - 12/2008
15	Parkinsonian Disorders (Parkinsonism) 01/2019 - 06/2003
13	Tauopathies 01/2021 - 09/2010
13	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2003
12	Disease Progression 01/2021 - 09/2002
12	Infections 01/2017 - 09/2002
9	Mitochondrial Diseases (Mitochondrial Disease) 07/2020 - 01/2003
9	Memory Disorders (Memory Loss) 01/2019 - 11/2010
9	Neuroblastoma 01/2019 - 06/2003
8	Frontotemporal Dementia (Semantic Dementia) 10/2017 - 10/2006
8	Acquired Immunodeficiency Syndrome (AIDS) 02/2008 - 05/2002
6	Atrophy 11/2018 - 03/2009
6	Prion Diseases (Transmissible Spongiform Encephalopathies) 02/2014 - 09/2007
5	Amyloidosis 01/2022 - 03/2003
5	Neoplasms (Cancer) 01/2021 - 12/2013
5	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2018 - 08/2012
4	Chronic Disease (Chronic Diseases) 01/2021 - 03/2009
4	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2017 - 09/2007
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2015 - 10/2006
4	Stroke (Strokes) 10/2012 - 09/2007
4	Scrapie 08/2012 - 06/2005
3	Schizophrenia (Dementia Praecox) 01/2019 - 09/2008
3	Corticobasal Degeneration 01/2018 - 08/2012
3	Demyelinating Diseases (Demyelinating Disease) 01/2018 - 09/2014
3	Proteostasis Deficiencies 01/2016 - 07/2009
3	Ataxia (Dyssynergia) 09/2015 - 11/2005

Drug/Important Bio-Agent (IBA)

126	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2001
106	SynucleinsIBA 05/2022 - 06/2003
86	alpha-SynucleinIBA 12/2021 - 10/2001
84	Amyloid (Amyloid Fibrils)IBA 01/2022 - 02/2001
34	Amyloid beta-PeptidesIBA 01/2020 - 07/2002
29	Peptides (Polypeptides)IBA 01/2020 - 08/2002
17	PrionsIBA 12/2020 - 03/2004
12	CalciumIBA 01/2017 - 08/2003
11	CytokinesIBA 01/2021 - 11/2003
11	polyglutamineIBA 01/2018 - 07/2009
11	cerebrolysinIBA 01/2016 - 05/2006
10	Amyloidogenic ProteinsIBA 01/2022 - 09/2006
10	Phosphotransferases (Kinase)IBA 01/2018 - 09/2002
10	ApolipoproteinsIBA 01/2018 - 02/2002
9	AdiponectinIBA 01/2022 - 07/2014
9	Protein AggregatesIBA 12/2021 - 06/2009
9	EnzymesIBA 01/2021 - 09/2007
9	Apolipoproteins E (ApoE)IBA 01/2019 - 12/2002
9	AntibodiesIBA 01/2018 - 09/2010
9	SynaptophysinIBA 01/2017 - 12/2002
8	Neuroprotective AgentsIBA 06/2020 - 02/2007
8	Biomarkers (Surrogate Marker)IBA 01/2016 - 09/2007
8	beta-SynucleinIBA 05/2009 - 08/2002
7	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021 - 03/2004
7	Pharmaceutical PreparationsIBA 11/2019 - 04/2005
7	Apolipoprotein E4IBA 01/2019 - 02/2002
7	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017 - 03/2009
6	VaccinesIBA 01/2022 - 02/2010
6	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2005
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2007
6	tau Proteins (tau Protein)IBA 10/2019 - 01/2011
6	Glial Fibrillary Acidic ProteinIBA 01/2017 - 07/2003
6	Cholinergic Agents (Cholinergics)IBA 10/2015 - 10/2002
5	Protein Isoforms (Isoforms)IBA 01/2021 - 10/2001
5	UbiquitinIBA 01/2021 - 10/2006
5	Prion ProteinsIBA 12/2020 - 06/2005
5	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2020 - 09/2005
5	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2014 - 12/2003
4	Biological ProductsIBA 01/2021 - 01/2008
4	Glucosylceramidase (Glucocerebrosidase)IBA 01/2021 - 08/2014
4	Toll-Like Receptor 2IBA 01/2021 - 10/2015
4	InterferonsIBA 10/2020 - 12/2013
4	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2020 - 03/2010
4	CaspasesIBA 09/2015 - 12/2003
4	Beclin-1IBA 09/2013 - 06/2008
4	Peptide Hydrolases (Proteases)FDA Link 08/2012 - 06/2005
4	Neprilysin (Neutral Endopeptidase)IBA 01/2011 - 03/2003
4	CholesterolIBA 02/2010 - 08/2006
3	Apolipoproteins B (ApoB)IBA 01/2022 - 01/2015
3	LipidsIBA 09/2019 - 08/2006
3	Small Interfering RNA (siRNA)IBA 01/2019 - 10/2005
3	CalpainIBA 12/2018 - 05/2007
3	MicroRNAs (MicroRNA)IBA 01/2017 - 04/2010
3	Nerve Growth Factor (NGF)IBA 01/2016 - 02/2013
3	Complement System Proteins (Complement)IBA 09/2012 - 08/2002

Therapy/Procedure

43	Therapeutics 01/2022 - 05/2002
20	Immunotherapy 01/2020 - 10/2005
10	Highly Active Antiretroviral Therapy (HAART) 06/2014 - 05/2002
4	Transplantation 06/2020 - 04/2014